SEC CIK 1195643
DENHAM ROBERT E
Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| NYTview stock → | 57,382 | 2021-04-22 |
| CVXview stock → | 49,279 | 2017-05-31 |
Position History — NYT
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — NYT
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2021-04-28 | Grant / award (derivative) | 192.06 | — | 37,466.09 |
| 2021-04-22 | Grant / award | 46 | $0.00 | 57,382 |
| 2021-01-21 | Grant / award | 38 | $0.00 | 57,336 |
| 2020-10-22 | Grant / award | 43 | $0.00 | 57,298 |
| 2020-07-23 | Grant / award | 42 | $0.00 | 57,255 |
| 2020-04-23 | Grant / award | 57 | $0.00 | 57,213 |
| 2020-04-22 | Grant / award (derivative) | 251.01 | — | 37,274.03 |
| 2020-04-22 | Grant / award | 3,764 | $0.00 | 57,156 |
| 2020-01-23 | Grant / award | 41 | $0.00 | 53,392 |
| 2019-10-17 | Grant / award | 46 | $0.00 | 53,351 |
| 2019-07-25 | Grant / award | 38 | $0.00 | 53,305 |
| 2019-05-02 | Grant / award (derivative) | 189.72 | — | 37,023.03 |
| 2019-05-02 | Grant / award | 3,447 | $0.00 | 53,267 |
| 2019-04-18 | Grant / award | 36 | $0.00 | 49,820 |
| 2019-01-24 | Grant / award | 39 | $0.00 | 49,784 |
| 2018-11-05 | Option exercise (derivative) | 4,000 | $0.00 | 0 |
| 2018-11-05 | Option exercise (derivative) | 4,000 | $0.00 | 8,000 |
| 2018-11-05 | Option exercise (derivative) | 4,000 | $0.00 | 4,000 |
| 2018-11-05 | Option exercise | 4,000 | $10.79 | 49,237 |
| 2018-11-05 | Option exercise | 4,000 | $4.92 | 45,237 |
| 2018-11-05 | Open-market sale | 3,492 | $27.84 | 49,745 |
| 2018-11-05 | Option exercise | 4,000 | $8.57 | 53,237 |
| 2018-10-18 | Grant / award | 36 | $0.00 | 41,237 |
| 2018-07-26 | Grant / award | 40 | $0.00 | 41,201 |
| 2018-04-19 | Grant / award (derivative) | 311.62 | — | 36,833.3 |
| 2018-04-19 | Grant / award | 36 | $0.00 | 41,161 |
| 2018-04-19 | Grant / award | 4,449 | $0.00 | 41,125 |
| 2018-02-16 | Option exercise (derivative) | 4,000 | $0.00 | 0 |
| 2018-02-16 | Open-market sale | 3,166 | $25.12 | 36,676 |
| 2018-02-16 | Option exercise | 4,000 | $19.88 | 39,842 |
| 2018-01-25 | Grant / award | 36 | $0.00 | 35,842 |
| 2017-10-19 | Grant / award | 43 | $0.00 | 35,806 |
| 2017-07-27 | Grant / award | 41 | $0.00 | 35,763 |
| 2017-04-20 | Grant / award | 37 | $0.00 | 35,722 |
| 2017-04-19 | Grant / award (derivative) | 301.8 | — | 36,521.69 |
| 2017-04-19 | Grant / award | 6,843 | $0.00 | 35,685 |
| 2017-01-26 | Grant / award | 41 | $0.00 | 28,842 |
| 2016-10-20 | Grant / award | 47 | $0.00 | 28,801 |
| 2016-07-28 | Grant / award | 42 | $0.00 | 28,754 |
| 2016-05-04 | Grant / award (derivative) | 452.44 | — | 36,219.89 |
| 2016-05-04 | Grant / award | 8,080 | $0.00 | 28,712 |
| 2016-04-21 | Grant / award | 17 | $0.00 | 20,632 |
| 2016-01-28 | Grant / award | 17 | $0.00 | 20,615 |
| 2015-10-22 | Grant / award | 17 | $0.00 | 20,598 |
| 2015-07-30 | Grant / award | 16 | $0.00 | 20,581 |
| 2015-05-06 | Grant / award (derivative) | 423.51 | — | 35,767.44 |
| 2015-05-06 | Grant / award | 5,565 | $0.00 | 20,565 |
| 2014-04-30 | Grant / award (derivative) | 3,892.72 | — | 35,343.93 |
| 2013-05-01 | Grant / award (derivative) | 6,357.28 | — | 31,451.22 |
| 2012-04-25 | Grant / award (derivative) | 9,111.2 | — | 25,093.94 |
| 2011-04-27 | Grant / award (derivative) | 3,798.44 | — | 15,982.74 |
| 2011-04-27 | Grant / award (derivative) | 4,000 | — | 4,000 |
| 2010-04-27 | Grant / award (derivative) | 4,000 | — | 4,000 |
| 2010-04-27 | Grant / award (derivative) | 3,020.29 | — | 12,184.29 |
| 2009-04-23 | Grant / award (derivative) | 4,000 | — | 4,000 |
| 2009-04-23 | Grant / award (derivative) | 7,348.18 | — | 9,164 |
| 2008-04-22 | — | — | — | 15,000 |
| 2008-04-22 | Grant / award (derivative) | 1,815.82 | — | 1,815.82 |
| 2008-04-22 | Grant / award (derivative) | 4,000 | — | 4,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.